Presto Automation Inc. Announces Second Quarter Fiscal 2023 Financial Results
Continues momentum with Presto Voice A.I. platform by adding
“It has been exciting to see artificial intelligence gain mainstream recognition with the emergence of chatGPT and large language models (LLMs). One of our early investors was
Second Quarter 2023 Financial Highlights
For the second quarter of fiscal 2023, compared to the second quarter of fiscal 2022:
- Total Revenue: Total revenue was
$7.4 million down 4% compared to$7.7 million for 2022. - ARR: ARR was
$29 million , a decrease of 4% year-over-year. ARR would have been$32 million but for the accounting treatment related to a specific customer contract that precluded the recognition of certain revenues related to the contract. - Net Loss: Net loss improved to
$(17) million , compared to$(24) million for 2022. - Adjusted EBITDA*: Adjusted EBITDA loss was
$(10) million for 2023, compared to$(5) million for 2022.
Second Quarter 2023 Business Highlights
- Signed Del Taco as second enterprise customer Voice A.I. for drive-thru.
- Initiated expense rationalization program in effort to reduce overall operating expenses.
*Adjusted EBITDA is a non-GAAP financial measure defined under “Non-GAAP Financial Measures,” and is reconciled to net income, the closest comparable GAAP measure, at the end of this release.
Financial Outlook Update
- For the fiscal year ending
June 30, 2023 :- The Company expects reported ARR to be between
$28 -$30 million .
- The Company expects reported ARR to be between
Second Quarter 2023 Conference Call
Non-GAAP Financial Measures and Definition of Key Metric
This press release includes Adjusted EBITDA, which is a financial measure that is not calculated in accordance with Generally Accepted Accounting Principles in
Adjusted EBITDA is defined as net loss, adjusted to exclude interest, other income (expense), net loss on debt extinguishment, income taxes, depreciation and amortization expense, stock-based compensation expense, fair value adjustments on warrant liabilities and convertible promissory notes, merger related ancillary costs, and hardware repair expenses related to COVID and COVID-related expenses due to damage from liquid ingress.
We include this non-GAAP measure because it used by management to evaluate our core operating performance and trends and to make strategic decisions regarding the allocation of capital and new investments. A reconciliation of Adjusted EBITDA to its most comparable GAAP financial measure is included below under “Reconciliation from GAAP to Non-GAAP Results” at the end of this release.
In addition, we use Annual Revenue Run-Rate, or ARR, as a key business metric to evaluate our business, identify trends, formulate business plans and make strategic decisions. We calculate ARR by annualizing quarterly revenue at the end of the fiscal quarter. Our calculation of ARR may differ from similarly titled metrics presented by other companies, and the amount of revenue we recognize over any 12-month period may differ significantly from the ARR at the beginning of that period.
About Presto
Presto overlays next-generation digital solutions onto the physical world. Our enterprise-grade touch, vision, and voice technologies help hospitality businesses thrive while delighting guests. With over 250,000 systems shipped, we are one of the largest labor automation technology providers in the industry. Founded by a number of
|
||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) |
||||||||||||||||||
(unaudited) |
||||||||||||||||||
(in thousands, except per share and per share amounts) |
||||||||||||||||||
Three Months Ended |
|
Six Months Ended |
||||||||||||||||
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||||||
Revenue |
||||||||||||||||||
Platform |
$ |
4,131 |
|
$ |
5,134 |
|
$ |
8,529 |
|
$ |
9,671 |
|
||||||
Transaction |
|
3,221 |
|
|
2,562 |
|
|
6,180 |
|
|
5,254 |
|
||||||
Total revenue |
|
7,352 |
|
|
7,696 |
|
|
14,709 |
|
|
14,925 |
|
||||||
Cost of revenue: |
||||||||||||||||||
Platform |
|
4,219 |
|
|
3,793 |
|
|
8,208 |
|
|
7,815 |
|
||||||
Transaction |
|
2,833 |
|
|
2,230 |
|
|
5,477 |
|
|
4,564 |
|
||||||
Depreciation and impairment |
|
291 |
|
|
461 |
|
|
582 |
|
|
927 |
|
||||||
Total cost of revenue |
|
7,343 |
|
|
6,484 |
|
|
14,267 |
|
|
13,306 |
|
||||||
Gross profit |
|
9 |
|
|
1,212 |
|
|
442 |
|
|
1,619 |
|
||||||
Operating expenses: |
||||||||||||||||||
Research and development (1) |
|
5,112 |
|
|
3,805 |
|
|
11,381 |
|
|
7,806 |
|
||||||
Sales and marketing (1) |
|
2,227 |
|
|
1,651 |
|
|
4,626 |
|
|
2,825 |
|
||||||
General and administrative (1) |
|
6,276 |
|
|
2,158 |
|
|
12,200 |
|
|
4,132 |
|
||||||
Loss on infrequent product repairs |
|
- |
|
|
28 |
|
|
- |
|
|
463 |
|
||||||
Total operating expenses |
|
13,615 |
|
|
7,642 |
|
|
28,207 |
|
|
15,226 |
|
||||||
Loss from operations |
|
(13,606 |
) |
|
(6,430 |
) |
|
(27,765 |
) |
|
(13,607 |
) |
||||||
Change in fair value of warrants and convertible promissory notes |
|
(378 |
) |
|
(16,196 |
) |
|
59,444 |
|
|
(29,770 |
) |
||||||
Interest expense |
|
(3,030 |
) |
|
(868 |
) |
|
(6,406 |
) |
|
(2,256 |
) |
||||||
Loss on early extinguishment of debt |
|
(337 |
) |
|
- |
|
|
(8,095 |
) |
|
- |
|
||||||
Other financing and financial instrument (costs) income, net |
|
- |
|
|
- |
|
|
(1,768 |
) |
|
- |
|
||||||
Other income, net |
|
327 |
|
|
11 |
|
|
2,355 |
|
|
2,641 |
|
||||||
Total other income (expense), net |
|
(3,418 |
) |
|
(17,053 |
) |
|
45,530 |
|
|
(29,385 |
) |
||||||
Income (loss) before provision for income taxes |
|
(17,024 |
) |
|
(23,483 |
) |
|
17,765 |
|
|
(42,992 |
) |
||||||
Provision for income taxes |
|
5 |
|
|
24 |
|
|
5 |
|
|
24 |
|
||||||
Net income (loss) and comprehensive income (loss) |
$ |
(17,029 |
) |
$ |
(23,507 |
) |
$ |
17,760 |
|
$ |
(43,016 |
) |
||||||
Net income (loss) per share attributable to common stockholders: |
||||||||||||||||||
Basic |
$ |
(0.33 |
) |
$ |
(0.86 |
) |
$ |
0.44 |
|
$ |
(1.58 |
) |
||||||
Diluted |
$ |
(0.33 |
) |
$ |
(0.86 |
) |
$ |
0.35 |
|
$ |
(1.58 |
) |
||||||
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic |
|
50,998,941 |
|
|
27,211,309 |
|
|
40,475,200 |
|
|
27,157,425 |
|
||||||
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted |
|
50,998,941 |
|
|
27,211,309 |
|
|
50,775,172 |
|
|
27,157,425 |
|
||||||
(1) |
Includes stock-based compensation expense as follows (in thousands) |
|||||||||||||||||
Three Months Ended |
|
Six Months Ended |
||||||||||||||||
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||||||
Research and development |
$ |
555 |
|
$ |
145 |
|
$ |
732 |
|
$ |
250 |
|
||||||
Sales and marketing |
|
224 |
|
|
114 |
|
|
336 |
|
|
213 |
|
||||||
General and administrative |
|
1,749 |
|
|
210 |
|
|
3,808 |
|
|
485 |
|
||||||
Total* |
$ |
2,528 |
|
$ |
469 |
|
$ |
4,876 |
|
$ |
948 |
|
||||||
*For the three and six months ended |
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(unaudited) |
||||||||
(in thousands, except share and par value) |
||||||||
|
|
|
||||||
2022 |
|
2022 |
||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
38,211 |
|
$ |
3,017 |
|
||
Accounts receivable, net |
|
2,572 |
|
|
1,518 |
|
||
Inventories |
|
649 |
|
|
869 |
|
||
Deferred costs, current |
|
4,780 |
|
|
8,443 |
|
||
Prepaid expenses and other current assets |
|
2,265 |
|
|
707 |
|
||
Total current assets |
|
48,477 |
|
|
14,554 |
|
||
Deferred costs, net of current portion |
|
436 |
|
|
2,842 |
|
||
Investment in non-affiliate |
|
2,000 |
|
|
- |
|
||
Deferred transaction costs |
|
- |
|
|
5,765 |
|
||
Property and equipment, net |
|
1,489 |
|
|
1,975 |
|
||
Intangible assets, net |
|
6,942 |
|
|
4,226 |
|
||
|
|
1,156 |
|
|
1,156 |
|
||
Other long-term assets |
|
674 |
|
|
18 |
|
||
Total assets |
$ |
61,174 |
|
$ |
30,536 |
|
||
LIABILITIES AND STOCKHOLDERS' DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ |
2,982 |
|
$ |
5,916 |
|
||
Accrued liabilities |
|
4,356 |
|
|
6,215 |
|
||
Financing obligations, current |
|
6,786 |
|
|
8,840 |
|
||
Term loans, current |
|
- |
|
|
25,443 |
|
||
Convertible promissory notes and embedded warrants, current |
|
- |
|
|
89,663 |
|
||
Deferred revenue, current |
|
3,533 |
|
|
10,532 |
|
||
Total current liabilities |
|
17,657 |
|
|
146,609 |
|
||
Term loans, noncurrent |
|
52,022 |
|
|
- |
|
||
PPP loans |
|
- |
|
|
2,000 |
|
||
Warrant liabilities |
|
2,362 |
|
|
4,149 |
|
||
Deferred revenue, net of current portion |
|
609 |
|
|
237 |
|
||
Other long-term liabilities |
|
748 |
|
|
- |
|
||
Total liabilities |
$ |
73,398 |
|
$ |
152,995 |
|
||
Stockholders' deficit: |
||||||||
Preferred stock, |
|
- |
|
|
- |
|
||
Common stock, |
|
5 |
|
|
3 |
|
||
Additional paid-in capital |
|
170,794 |
|
|
78,321 |
|
||
Accumulated deficit |
|
(183,023 |
) |
|
(200,783 |
) |
||
Total stockholders' deficit |
|
(12,224 |
) |
|
(122,459 |
) |
||
Total liabilities and stockholders' deficit |
$ |
61,174 |
|
$ |
30,536 |
|
|
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(unaudited) |
||||||||
(in thousands) |
||||||||
Six Months Ended |
||||||||
2022 |
|
2021 |
||||||
Cash Flows from Operating Activities |
|
|
||||||
Net income (loss) |
$ |
17,760 |
|
$ |
(43,016 |
) |
||
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
||||||
Depreciation, amortization and impairment |
|
845 |
|
|
1,053 |
|
||
Stock-based compensation |
|
3,002 |
|
|
954 |
|
||
Earnout share stock-based compensation expense to option and RSU holders |
|
1,874 |
|
|
- |
|
||
Contra-revenue associated with warrant agreement |
|
615 |
|
|
- |
|
||
Noncash expense attributable to fairvalue liabilities assumed in Merger |
|
34 |
|
|
- |
|
||
Change in fair value of liability classified warrants |
|
(11,188 |
) |
|
2,768 |
|
||
Change in fair value of warrants and convertible promissory notes |
|
(48,271 |
) |
|
26,909 |
|
||
Amortization of debt discount and debt issuance costs |
|
1,884 |
|
|
175 |
|
||
Loss on extinguishment of debt and financing obligations |
|
8,095 |
|
|
- |
|
||
Paid-in-kind interest expense |
|
2,366 |
|
|
- |
|
||
Share and warrant cost on termination of convertible note agreement |
|
2,412 |
|
|
- |
|
||
Forgiveness of PPP Loan |
|
(2,000 |
) |
|
(2,599 |
) |
||
Change in fair value of unvested founder shares liability |
|
(1,160 |
) |
|
- |
|
||
Noncash lease expense |
|
168 |
|
|
- |
|
||
Loss on disposal of property and equipment |
|
14 |
|
|
- |
|
||
Changes in operating assets and liabilities: |
|
|
||||||
Accounts receivable, net |
|
(1,054 |
) |
|
(459 |
) |
||
Inventories |
|
219 |
|
|
(321 |
) |
||
Deferred costs |
|
6,308 |
|
|
5,958 |
|
||
Prepaid expenses and other current assets |
|
(1,155 |
) |
|
599 |
|
||
Other long-term assets |
|
- |
|
|
(83 |
) |
||
Accounts payable |
|
1,388 |
|
|
(4,777 |
) |
||
Vendor financing facility |
|
- |
|
|
(6,792 |
) |
||
Accrued liabilities |
|
(2,090 |
) |
|
(2,656 |
) |
||
Deferred revenue |
|
(6,627 |
) |
|
(7,305 |
) |
||
Other long-term liabilities |
|
- |
|
|
(699 |
) |
||
Net cash used in operating activities |
|
(26,561 |
) |
|
(30,291 |
) |
||
|
|
|||||||
Cash Flows from Investing Activities |
|
|
||||||
Purchase of property and equipment |
|
(171 |
) |
|
(109 |
) |
||
Payments relating to capitalized software |
|
(2,459 |
) |
|
(787 |
) |
||
Investment in non-affiliate |
|
(2,000 |
) |
|
||||
Net cash used in investing activities |
|
(4,630 |
) |
|
(896 |
) |
||
|
|
|||||||
Cash Flows from Financing Activities |
|
|
||||||
Proceeds from the exercise of common stock options |
|
60 |
|
|
58 |
|
||
Proceeds from the issuance of term loans |
|
60,250 |
|
|
- |
|
||
Payment of debt issuance costs |
|
(1,094 |
) |
|
- |
|
||
Repayment of term loans |
|
(32,980 |
) |
|
- |
|
||
Payment of penalties and other costs on extinguishment of debt |
|
(6,144 |
) |
|
||||
Proceeds from issuance of convertible promissory notes and embedded warrants |
|
- |
|
|
500 |
|
||
Proceeds from issuance of financing obligations |
|
- |
|
|
439 |
|
||
Principal payments of financing obligations |
|
(2,657 |
) |
|
(978 |
) |
||
Proceeds from issuance of common stock |
|
1,000 |
|
|
- |
|
||
Contributions from Merger and PIPE financing, net of transaction costs and other payments |
|
49,840 |
|
|
- |
|
||
Payment of deferred transaction costs |
|
(1,890 |
) |
|
(105 |
) |
||
Net cash provided (used in) by financing activities |
|
66,385 |
|
|
(86 |
) |
||
|
|
|||||||
Net increase (decrease) in cash and cash equivalents |
|
35,194 |
|
|
(31,273 |
) |
||
Cash and cash equivalents at beginning of year |
|
3,017 |
|
|
36,909 |
|
||
Cash and cash equivalents at end of year |
$ |
38,211 |
|
$ |
5,636 |
|
||
|
|
|||||||
Supplemental Disclosure of Non-Cash Investing and Financing Activities |
|
|
||||||
Capitalization of stock-based compensation expense to capitalized software |
$ |
459 |
|
$ |
9 |
|
||
Issuance of warrants |
|
853 |
|
$ |
- |
|
||
Capital contribution from shareholder in conjunction with Credit Agreement |
|
2,779 |
|
|
- |
|
||
Issuance of warrants in conjunction with Senior Term Loan |
|
2,076 |
|
|
- |
|
||
Issuance of warrants in conjunction with Lago Term Loan |
|
843 |
|
|
- |
|
||
Convertible note conversion to common stock |
|
41,392 |
|
|
- |
|
||
Reclassification of warrants from liabilities to equity |
|
830 |
|
|
- |
|
||
Recognition of liability classified warrants upon Merger |
|
9,388 |
|
|
- |
|
||
Recognition of Unvested Founder Shares liability |
|
1,588 |
|
|
- |
|
||
Forgiveness of PPP Loan |
|
(2,000 |
) |
|
(2,599 |
) |
||
Transaction costs recorded in accounts payable and accrued liabilities |
|
- |
|
|
3,720 |
|
||
Right of use asset in exchange for operating lease liability |
|
308 |
|
|
- |
|
|
||||||||||||||||
Reconciliation from GAAP to Non-GAAP Results |
||||||||||||||||
(In thousands, except per share data, unaudited) |
||||||||||||||||
Three Months Ended |
|
Six Months Ended |
||||||||||||||
|
|
|
||||||||||||||
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||||
Adjusted EBITDA |
|
|
|
|
||||||||||||
Net income (loss) |
|
(17,029 |
) |
|
(23,507 |
) |
|
17,760 |
|
|
(43,016 |
) |
||||
Interest expense |
|
3,030 |
|
|
868 |
|
|
6,406 |
|
|
2,256 |
|
||||
Other income, net |
|
(327 |
) |
|
(11 |
) |
|
(2,355 |
) |
|
(2,641 |
) |
||||
Depreciation and amortization |
|
412 |
|
|
518 |
|
|
845 |
|
|
1,053 |
|
||||
Provision for Income taxes |
|
5 |
|
|
24 |
|
|
5 |
|
|
24 |
|
||||
Stock-based compensation expense |
|
827 |
|
|
475 |
|
|
3,002 |
|
|
954 |
|
||||
Earnout stock-based compensation expense |
|
1,696 |
|
|
- |
|
|
1,874 |
|
|
- |
|
||||
Change in fair value of warrants and convertible promissory notes |
|
378 |
|
|
16,196 |
|
|
(59,444 |
) |
|
29,770 |
|
||||
Loss on extinguishment of debt and financial obligations |
|
337 |
|
|
- |
|
|
8,095 |
|
|
- |
|
||||
Other financing and financial instrument (costs) income, net |
|
- |
|
|
- |
|
|
1,768 |
|
|
- |
|
||||
Deferred compensation and bonuses earned upon closing of the Merger |
|
- |
|
|
- |
|
|
2,232 |
|
|
- |
|
||||
Public relations fee due upon closing of the Merger |
|
- |
|
|
- |
|
|
250 |
|
|
- |
|
||||
Loss on infrequent product repairs |
|
- |
|
|
28 |
|
|
- |
|
|
463 |
|
||||
Contra-revenue associated with warrant agreement |
|
409 |
|
|
- |
|
|
615 |
|
|
- |
|
||||
Hardware repair expense related to COVID |
|
- |
|
|
737 |
|
|
- |
|
|
1,110 |
|
||||
Adjusted EBITDA |
$ |
(10,262 |
) |
$ |
(4,672 |
) |
$ |
(18,947 |
) |
$ |
(10,027 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230214005850/en/
Investors:
investor@presto.com
Media:
media@presto.com
Source: